Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

iSpecimen Q4 2023 GAAP EPS $(0.34) Misses $(0.24) Estimate, Sales $2.575M Miss $3.041M Estimate

Author: Benzinga Newsdesk | March 13, 2024 05:39pm
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.24) by 41.67 percent. The company reported quarterly sales of $2.575 million which missed the analyst consensus estimate of $3.041 million by 15.32 percent. This is a 13.07 percent decrease over sales of $2.962 million the same period last year.

Posted In: ISPC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist